Principal Financial Group
MBIO icon

Principal Financial Group’s Mustang Bio MBIO Stock Holding History

Principal Financial Group’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-14
Closed -$10K – 2594
2022
Q1 		$10K Hold
14
– – ﹤0.01% 2533
2021
Q4 		$18K Sell
14
-3
-18% -$4.84K ﹤0.01% 2515
2021
Q3 		$34K Sell
17
-3
-15% -$6.44K ﹤0.01% 2551
2021
Q2 		$49K Buy
20
+5
+33% +$12.3K ﹤0.01% 2574
2021
Q1 		$37K Sell
15
-2
-12% -$5.95K ﹤0.01% 2466
2020
Q4 		$48K Buy
+17
New +$40.6K ﹤0.01% 2396

Other funds holding MBIO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return

Principal Financial Group's MBIO Position: Q2 2022 in Review

Principal Financial Group sold out of Mustang Bio (MBIO) in Q2 2022, closing a stake of 14 shares — an estimated $10K sold.

Principal Financial Group first reported a position in MBIO in Q4 2020 and held it in 6 quarters. The position peaked at $49K in Q2 2021. 71 funds tracked by Wall St. Rank hold MBIO as of Q2 2022.

  • Principal Financial Group reported no remaining Mustang Bio position as of Q2 2022 after selling out during the quarter.
  • Principal Financial Group sold 14 Mustang Bio shares in Q2 2022, an estimated $10K.
  • Principal Financial Group first reported a position in Mustang Bio in Q4 2020 and held it in 6 quarters.
  • Principal Financial Group's Mustang Bio position peaked at $49K in Q2 2021.
  • 71 funds tracked by Wall St. Rank held Mustang Bio as of Q2 2022.

Based on Principal Financial Group's 13F filing for Q2 2022, filed 10 Aug 2022.